Purple Biotech (PPBT) Short-term Investments (2015 - 2026)
Purple Biotech (PPBT) reported Short-term Investments of $859000.0 for Q1 2026, up 1.54% year-over-year from $846000.0 in Q1 2025, and little changed quarter-over-quarter from $857000.0 in Q4 2025.
Purple Biotech (PPBT) Short-term Investments (2015 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 12 years of Short-term Investments data on file, last reported at $859000.0 in Q1 2026.
- Short-term Investments for Q1 2026 came in at $859000.0, up 1.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $859000.0 (up 1.54% YoY), and the FY2025 annual result was $857000.0, up 211.64% from the prior year.
- Short-term Investments steadied at $859000.0 in Q1 2026 per PPBT's latest filing, from $857000.0 in the prior quarter.
- Over five years, Short-term Investments peaked at $22.0 million in Q2 2022 and troughed at $275000.0 in Q4 2024.
- A 5-year average of $4.2 million and a median of $849000.0 in 2023 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2022 and 2025: Short-term Investments plunged 98.81% in 2022, then surged 211.64% in 2025.
- A 5-year view of Short-term Investments shows it stood at $431000.0 in 2022, then soared by 97.22% to $850000.0 in 2023, then sank by 67.65% to $275000.0 in 2024, then surged by 211.64% to $857000.0 in 2025, then climbed by 0.23% to $859000.0 in 2026.
- Business Quant data shows PPBT's Short-term Investments at $859000.0 in Q1 2026, $857000.0 in Q4 2025, and $862000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Purple Biotech | 261.30 Mn | 254.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 859,000.00 |
| Dec 31, 2025 | 857,000.00 |
| Sep 30, 2025 | 862,000.00 |
| Jun 30, 2025 | 857,000.00 |
| Mar 31, 2025 | 846,000.00 |
| Dec 31, 2024 | 275,000.00 |
| Sep 30, 2024 | 848,000.00 |
| Jun 30, 2024 | 845,000.00 |
| Mar 31, 2024 | 848,000.00 |
| Dec 31, 2023 | 850,000.00 |
| Sep 30, 2023 | 842,000.00 |
| Jun 30, 2023 | 846,000.00 |
| Mar 31, 2023 | 849,000.00 |
| Dec 31, 2022 | 431,000.00 |
| Sep 30, 2022 | 22.01 Mn |
| Jun 30, 2022 | 22.01 Mn |
| Mar 31, 2022 | 16.01 Mn |
| Dec 31, 2021 | 36.31 Mn |
| Sep 30, 2021 | 36.45 Mn |
| Jun 30, 2021 | 37.85 Mn |